A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.

CONCLUSIONS: The I.M. injection of NE02 adjuvanted rH5 elicits strong and broad immune responses against H5 antigens and effectively protects animals from lethal H5 challenge. Combining this adjuvant with CpG enhanced immune responses and provided improvements in outcomes to viral challenge in ferrets. The results suggest that combinations of adjuvants may be useful to enhance H5 immune responses and improve protection against influenza infection. PMID: 32245642 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32245642?dopt=Abstract

Source: Vaccine - March 30, 2020 Category: Allergy & Immunology Authors: Wang SH, Chen J, Smith D, Cao Z, Acosta H, Fan Y, Ciotti S, Fattom A, Baker J Tags: Vaccine Source Type: research